Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso

Size: px
Start display at page:

Download "Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso"

Transcription

1 Tropical Medicine and International Health doi: /j x volume 13 no 12 pp december 2008 Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso Judith E. Mueller 1, Seydou Yaro 2, Yoann Madec 3, Paulin K. Somda 2,Régina S. Idohou 1, Berthe-Marie Njanpop Lafourcade 1, Aly Drabo 2, Zekiba Tarnagda 4, Lassana Sangaré 5, Yves Traoré 6, Arnaud Fontanet 3 and Bradford D. Gessner 1 1 Agence de Médecine Préventive, Paris, France 2 Centre Muraz, Bobo-Dioulasso, Burkina Faso 3 Unité d Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France 4 Institut de Recherche en Science de la Santé, Bobo-Dioulasso, Burkina Faso 5 Centre Hospitalier Universitaire Yalgado Ouédraogo, Ouagadougou, Burkina Faso 6 Université de Ouagadougou, Ouagadougou, Burkina Faso Summary objectives To evaluate risk factors for meningococcal carriage and carriage acquisition in the African meningitis belt, comparing epidemic serogroup A (NmA) to non-epidemic serogroups. methods During the non-epidemic meningitis season of 2003, pharyngeal swabs were taken at five monthly visits in a representative population sample (N = 488) of Bobo-Dioulasso, Burkina Faso (age 4 29 years) and analysed by culture. Standardized questionnaires were administered. In 2006, a similar study was performed in 624 individuals (age 1 39 years) during an NmA meningitis epidemic. We evaluated serogroup-specific risk factors for carriage, carriage acquisition and clearance using multivariate logistic and Poisson regression, and a Cox proportional hazard model. results The prevalence of NmA carriage (current or recent pharyngitis or rhinitis) was 16% (31%) vs. 0% (9%) in the epidemic vs. the hyperendemic setting. During the epidemic situation, NmA carriage was significantly associated with recent sore throat (adjusted odds ratio (OR), 3.41) and current rhinitis (OR 2.65). During the non-epidemic meningitis season in 2003, air humidity (20 39% and 40%, compared to <20%) during the month before swabbing was significantly and positively associated with carriage acquisition of non-groupable meningococci (OR 2.18 and 1.55) and inversely with carriage clearance (hazard ratio 0.61 and 0.27, respectively). conclusion Respiratory tract infections may increase meningococcal carriage, and thus contribute to epidemic risk, in addition to seasonality in the meningitis belt. Humid climate may favour carriage of unencapsulated meningococci. These findings may help identifying interventions against epidemic and hyperendemic meningococcal meningitis due to non-vaccine serogroups. keywords Neisseria meningitidis, Africa, carrier state, risk factors, disease outbreaks, respiratory tract infections, weather Introduction Meningococcal meningitis causes a substantial burden of disease in sub-saharan Africa. The meningitis belt is characterised by high incidence of hyperendemic meningococcal disease during the dry season (about December through May) and by periodic large epidemics, mainly due to serogroup A (NmA) (Greenwood 1999). Serogroups W135 (NmW135) and X (NmX) also cause occasional epidemics in the region (Boisier et al. 2007; World Health Organization 2008). Recently, a conjugate polysaccharide meningococcal vaccine against serogroup A has been developed for sub- Saharan countries (LaForce et al. 2007). This vaccine is expected to prevent meningitis epidemics not only through direct protection of the vaccinee, but also indirectly by reducing the risk for acquisition and transmission of pharyngeal carriage. To predict and evaluate the impact of conjugate vaccine immunization strategies, and to develop complementary, possibly non-serogroup-specific preventive strategies oriented against carriage, risk factors for meningococcal carriage during the meningitis season in ª 2008 Blackwell Publishing Ltd 1543

2 sub-saharan Africa need to be better known. Sequence type 2859, the genotype of a major part of NmA currently identified in the meningitis belt (Traoré et al. 2006; Caugant & Nicolas 2007), seems to be rarely carried outside of epidemics (Mueller et al. 2006; Raghunathan et al. 2006). We conducted a carriage study during an NmA epidemic in western Burkina Faso in 2006 that offered a rare opportunity to study prevalence and risk factors for NmA carriage. Carriage of unencapsulated, and thus non-groupable meningococci (NmNG) probably induces immunity against non-capsular meningococcal structures and therefore against encapsulated meningococci (Kremastinou et al. 1999). NmNG carriage prevalence varies greatly between different studies in sub-saharan Africa (Mueller et al. 2006; Leimkugel et al. 2007) and was related to seasonality in a previous carriage study in Bobo-Dioulasso during 2003 (Mueller et al. 2007). We used these data to evaluate factors associated with acquisition and clearance of NmNG carriage in this previous study. Methods Carriage study during hyperendemic period in 2003: longitudinal study During February to June 2003 [a meningitis season without occurrence of an epidemic (Traoré et al. 2006)], we conducted a longitudinal meningococcal carriage study among a random sample of healthy residents of urban Bobo-Dioulasso (Burkina Faso), with examinations at five monthly clinic visits. Ten of 22 neighbourhoods of Bobo- Dioulasso were randomly selected, as were 25 household communities (compounds) in each neighbourhood, and one subject aged 4 14 years and years each from each compound. Epidemiological and microbiological methods were reported in detail elsewhere (Mueller et al. 2006, 2007). At all five visits, swabs were taken from the posterior pharyngeal wall via the mouth, and analyzed by established bacteriological methods (Poolman & Abdillahi 1988; Tenover et al. 1995; Nicolas et al. 1997; Maiden et al. 1998; World Health Organization 1999; Taha 2000).We also administered questionnaires to all participants, recording sociodemographic information, personal and family medical history related to meningitis, meningococcal vaccination status, active and passive smoking, kitchen smoke exposure, professional activity, crowding in household and literacy (if aged 15 years or older). Children under 9 years of age had weight and height measured in a standardized way with a simple medical scale and measuring board. Children below the third percentile of weight for height were considered to have malnutrition (Ge & Chang 2001). For the study period, the Bobo-Dioulasso airport meteorological service provided daily meteorological data including minimum temperature, relative air humidity and wind speed. For each visit, average values for preceding periods were calculated (previous week, 2 weeks and 1 month) using various cut-offs for categorisation or continuous variables. These meteorological variables were separately used in models, and only the best-fitting model is presented. Carriage study during epidemic in 2006: cross-sectional study During February and March 2006, the rural health centers Lena and Kofila, situated approximately 60 km east of Bobo-Dioulasso, reported a meningitis epidemic. Using exhaustive PCR-based surveillance, we estimated average and peak weekly incidence rates of 84 and 247 per for NmA meningitis during March. A mass vaccination campaign with meningococcal group A C polysaccharide vaccine was conducted in the 2- to 29-yearold population with high coverage during March 12 15, From the approximately 10 villages attending the two health centers, we selected three (Konkourouna, Kofila and Lena) representing a total population of about Proportionally to population size, trained study workers conducted two-stage cluster sampling in each village. In Konkourouna and Kofila, starting from the village center, pathway directions were randomly selected, along which they included every third compound. In Lena, where a demographic information system existed, compounds were randomly selected from the compound list. In each selected compound one individual in each of four age groups (1 4, 5 9, and years) was randomly selected, asked to provide informed consent, and invited to come to the study visit the following day at a central place of the village. Procedures of recruitment and bacteriology were the same as in the 2003 study, while minor modifications occurred on the questionnaire. For <10-year-old children, mid-upper arm circumference (MUAC) and height were measured in a standardized way using a simple measuring tape and a measuring board. Malnutrition was defined as a MUAC-for-height below two standard deviations (Mei et al. 1997). During the study, meteorological data were collected at the Bobo-Dioulasso airport. Statistical analysis We used data from both studies to evaluate risk factors for serogroup-specific carriage. Controls were participants that did not carry the respective serogroup, or, for alternative analyses, who did not carry any meningococcus. We used 1544 ª 2008 Blackwell Publishing Ltd

3 logistic regression models, which included random effects for individual and compound effects, thereby taking into account the cluster sampling design. Serogroup-specific acquisition rates were estimated using a random effect Poisson model. For evaluation of risk factors for NmNG carriage acquisition, acquisition was defined as isolation of a nongroupable meningococcus from a participant at a particular visit, given that at the previous visit, the participant did not have meningococcal carriage of the same pheno- and genotype. Incidence of carriage acquisition was estimated using a random effect Poisson model; two random effects were introduced in the model to account for the correlation between one subject s measurements (individual effect) and the correlation between subjects from the same compound (compound effect). The time at risk was the time interval between two consecutive visits, or half of this interval in case of carriage acquisition, as carriage acquisition was assumed to occur at the midpoint between the visit without and the visit with carriage. Moreover, after an observed carriage episode at a given visit, the participant was assumed to be again at risk for carriage acquisition from 2 weeks after the visit on, according to the previously estimated carriage episode duration of 30 days (Mueller et al. 2007). Risk factors for NmNG carriage clearance at visits after the acquisition event were analysed using a Cox proportional hazard model. In all analyses, visits were not considered if a participant reported relevant antibiotic treatment within the previous 4 weeks. All available variables were evaluated first for association with carriage in univariate models, of which, with the exception of age, sex and symptoms of respiratory infection, only variables contributing at a significance level of P < 0.2 are shown in Tables 1 and 3 (complete tables can be obtained from authors). Variables contributing at a significance level of P < 0.2 were included in a full multivariate model, from which factors were eliminated by stepwise backward selection, using likelihood ratio tests, until only variables contributing at a significance level of P < 0.1 remained. Statistical analyses were performed on STATA version 8.0 and 9.0, using the GLLAMM module (available at (Rabe-Hesketh et al. 2002, 2005) for multilevel modelling. Ethical approval The study protocols were approved by the Centre Muraz ethics committee (2003), and the Burkina Faso National Ethics Committee (2006). Participants or their guardians (for those aged less than 18 years) provided written informed consent. Results Carriage study during hyperendemic period in 2003 During the longitudinal study in 2003, meningococcal carriage was observed at 152 of the 2327 study visits. Meningococcal isolates were attributed to NmW135 (N = 28, 18%), X (N = 5, 3%), Y (N = 3, 2%) and 116 (76%) were non-serogroupable, auto- or poly-agglutinable (NmNG). NmNG carriage prevalence increased from 1.6% in February to 8.6% in May June (Figure 1), while encapsulated meningococci showed a constant prevalence of around 1.5%. Carriage acquisition rates per 100 personmonths were estimated as 1.51 (95% confidence interval [CI] ) for any Nm, 0.27 ( ) for NmW135 and 1.34 ( ) for NmNG, respectively. The monthly average of minimal air humidity increased from 16% in February to 55% in June (overall range 4 72%) (Figure 1). The median minimal temperature was 25.0 C (range C), and median wind speed was 4 m s (range 1 6). Given the absence of substantial variation in wind speed, we did not evaluate it in the models. Carriage of any encapsulated meningococcus (W135, X or Y) was associated with male sex (OR 3.04 [95%-CI ], P = 0.037) and age 10 to 19 years [compared to 4 9 years: OR 0.29 ( )]. During the person-months of follow-up, 81 carriage acquisition events of NmNG were observed. In multivariate analysis, being a student was protective, while higher air humidity during the 2 weeks before assessment was associated with increased risk of carriage acquisition (Table 2). At least one follow-up visit was observed for 70 NmNG acquisition events, of which 50 eventually were cleared. Adjusting for age and neighbourhood, higher air humidity during the month prior to carriage assessment was associated with reduced clearance of NmNG carriage: 20 39%, hazard ratio (HR) 0.61 (95%-CI ); and 40%, HR 0.27 ( ). In all analyses, no significant effect modification was found and using as controls participants who did not carry any meningococcus did not change the estimates. Carriage study during epidemic in 2006 During March 13 28, 2006 we examined 624 healthy residents. 134 (22%) of the 617 persons without antibiotic treatment were meningococcal carriers. Serogroup-specific carriage prevalence was 15% for NmA (N = 95), 6% for NmY (N = 35), and 0.6% for NmNG (N = 4). No isolates were found for serogroups B, C, W135 or X. Median minimal air humidity in Bobo-Dioulasso during the study period was 7.5% (range 3 27%), median minimal temperature was 25 C (23 27 C) and the median wind speed 3m s (2 5 m s). In multivariate analysis, age groups ª 2008 Blackwell Publishing Ltd 1545

4 Observation time (person-months) (total = ) Number of carriage acquisition events Crude incidence rate ratio (95% CI) Age (years) ( ) ( ) Sex Female Male ( ) Student No Yes ( ) Commercial or market profession No Yes ( ) 0.16 Illiteracy (if 15 years) No Yes ( ) Localisation of kitchen Outside Inside ( ) Previous self-reported respiratory infection No Yes ( ) 0.64 Recent sore throat No Yes ( ) Pharyngitisà No Yes No estimate Rhinitisà No Yes ( ) 0.53 Coughà No Yes ( ) 0.77 Tonsillitisà No Yes No estimate Month in which observation period started February March ( ) April ( ) May ( ) Minimal air humidity (average during 2 weeks prior to visit) <20% % ( ) 40% ( ) Global P-value Table 1 Characteristics of 488 study participants examined at 5 visits, contributed person time and incidence rate for carriage acquisition of non-groupable meningococci. Bobo-Dioulasso, February through June 2003 Crude incidence rate ratio as estimated in two-level model. Self-reported information; at first visit: 2 months prior to visit, at following visits: since last visit. àobserved during swabbing. 1 3 years and years had the lowest odds for NmA carriage, and residence in Kofila and five or more persons sharing the bedroom were also inversely associated with current NmA carriage. Recent sore throat, observed current rhinitis, recent meningitis in the family and male sex were positively associated with NmA carriage 1546 ª 2008 Blackwell Publishing Ltd

5 Carriage prevalence (%) incidence rate (/10 5 ) Carriage NmNG Air humidity Weekly incidence Oct Dec Feb Apr Jun Calendar week and month Figure 1 Meningococcal carriage prevalence in 488 individuals at 5 monthly study visits between February and June; notified meningitis weekly incidence rates in the sanitary districts Secteur 15 and Secteur 22; and minimal relative air humidity (weekly average) measured at local airport. Bobo-Dioulasso, For the second through fourth study visit, participants were randomly assigned to two groups that were examined in 2-week-intervals. Table 2 Effect estimates for risk factors of carriage acquisition of non-groupable meningococci. Bobo-Dioulasso, February through June 2003 IRR (95% CI) (Table 4). If any previous or current symptoms combined or previous or current pharyngitis and rhinitis combined replaced previous sore throat and current rhinitis in the final model, the respective effect estimates were, OR 2.12 (95%-CI 1.25, 3.58), P = 0.005; and OR 3.41 (1.98, 5.87), P < Similar to symptoms of pharyngitis and rhinitis (Tables 1 and 3), prevalence of any previous or current symptoms combined or previous or current pharyngitis and rhinitis combined was significantly higher in March 2006 (44.37 and 31.27%, respectively) than in March 2003 (22.69% and 9.24%,respectively) (both differences P < 0.001) Air humidity (%) Global P-value Student No Yes 0.49 ( ) Kitchen localisation Outside Inside 0.63 ( ) Minimal air humidity (average during 2 weeks prior to visit) <20% % 2.18 ( ) 40% 1.55 ( ) Parsimonious multivariate models (variables P < 0.10). Variable does not remain in final model with selection P < NmY carriage was associated with daily exposure to cigarette smoke, number of persons sharing dinner and participation in a meeting of >10 persons during the previous week (Table 4). Discussion During an NmA meningitis outbreak in Burkina Faso, we found that in addition to several risk factors previously documented in Africa and the industrialized world (Hassan-King et al. 1979; Blakebrough et al. 1982; Yazdankhah & Caugant 2004), previous or current symptoms of upper respiratory tract infection were associated with carriage of the outbreak strain. Previous authors have described an association between meningococcal disease outbreaks and symptoms of respiratory tract infection, especially during influenza outbreaks (Young et al. 1972; Cartwright et al. 1991; Huber et al. 1992; Makras et al. 2001). A study during an NmA epidemic in Chad reported an association between NmA carriage and self-reported recent fever, but not recent sore throat or cough (Moore et al. 1990). In the same study, carriage of respiratory viruses and mycoplasma was associated with NmA meningitis, and to a lesser extent with NmA carriage. A study after an epidemic in Burkina Faso reported that coughing, nasal congestion or sore throat during the preceding month were associated with carriage of the NmW135 outbreak strain among persons 15 years of age (Raghunathan et al. 2006). Some authors have proposed that viral infection may weaken pre-existing mucosal or general immunity, thereby increasing the risk for invasive disease (Young et al. 1972; Moore et al. 1990; Cartwright et al. 1991; Alonso & Taha 2003). Moreover, as our results suggest, upper respiratory tract infections may increase transmission and mucosal adhesion in the pharynx of bacteria like meningococci (Young et al. 1972; Alonso & Taha 2003; Jacoby et al. 2007). The observed relative risk of 3 may seem too small to make respiratory infections alone an explanation of the Nm epidemic. However, on the individual level, the association may have been underestimated, as recall of sore throat may be low and meningococcal colonization may be rapidly cleared through pre-existing immunity. In the population, the occurrence of an upper respiratory infection outbreak in 2006 (as indicated by the higher prevalence of respiratory infection symptoms) may increase sufficiently the frequency of NmA transmission and carriage, such that a particular individual in the community need not have a respiratory infection to be subject to a higher risk of NmA carriage acquisition and invasive disease. Under specific conditions given during the dry ª 2008 Blackwell Publishing Ltd 1547

6 Table 3 Characteristics of 617 study participants by meningococcal carriage. Burkina Faso, March 2006 NmA (n = 95) NmY (n = 35) n n (%) carriers OR (95% CI) Global P-value n (%) carriers OR (95% CI) Global P-value Age (8) 0.35 ( ) (3) 0.72 ( ) (18) 1 9 (5) (19) 1.03 ( ) 8 (5) 1.14 ( ) (20) 1.12 ( ) 10 (12) 2.84 ( ) (9) 0.45 ( ) 3 (4) 0.86 ( ) Sex Female (11) (5) Male (20) 2.24 ( ) 17 (6) 1.09 ( Cigarette smoking No (15) (5) Yes 13 3 (23) 1.79 ( ) 2 (15) 3.15 ( ) Student No (19) (6) Yes (14) 1.46 ( ) 8 (5) 0.86 ( ) Meningococcal vaccination (A C) during No (15) (6) Yes (20) 1.52 ( ) 6 (5) 0.82 ( ) Participation in meeting >10 persons during the previous week No (16) (5) Yes (12) 0.79 ( ) 9 (9) 1.98 ( ) Recent respiratory infection No (14) (6) Yes (28) 2.51 ( ) 2 (4) 0.76 ( ) Recent sore throat No (13) 1 < (5) Yes (33) 3.33 ( ) 6 (7) 1.35 ( ) Cough during the previous 2 months No (13) (6) Yes (17) 1.34 ( ) 16 (5) 0.87 ( ) Recent flu symptoms No (16) (6) Yes 75 8 (11) 0.58 ( ) 4 (5) 0.94 ( ) Pharyngitisà No (15) (6) NE Yes (28) 2.40 ( ) 0 Rhinitisà No (14) (5) Yes (23) 1.79 ( ) 6 (6) 1.25 ( ) Coughà No (14) (6) Yes (28) 2.42 ( ) 4 (6) 1.07 ( ) Tonsillitisà No (15) (5) Yes (17) 1.13 ( ) 7 (9) 1.91 ( ) Meningitis case in compound during previous month No (12) 1 < (6) Yes (30) 3.34 ( ) 6 (5) 0.95 ( ) Number of persons sharing meal with participant (19) (2) (17) 0.81 ( ) 11 (5) 2.71 ( ) > (11) 0.47 ( ) 20 (8) 4.42 ( ) 1548 ª 2008 Blackwell Publishing Ltd

7 Table 3 (Continued) NmA (n = 95) NmY (n = 35) n n (%) carriers OR (95% CI) Global P-value n (%) carriers OR (95% CI) Global P-value 5 persons sharing bedroom No (17) (6) Yes (10) 0.50 ( ) 9 (6) 1.08 ( ) Number of persons living in compound < (30) (1) (13) 0.32 ( ) 21 (5) 4.50 ( ) (13) 0.31 ( ) 12 (8) 7.02 ( ) Kitchen localisation Outside (17) (5) Inside (12) 0.63 ( ) 10 (6) 1.02 ( ) Hours per day spent in kitchen smoke < (30) (7) (15) 0.38 ( ) 24 (6) 0.88 ( ) > (11) 0.25 ( ) 6 (4) 0.48 ( ) Daily exposure to cigarette smoke No (14) (5) Yes (21) 1.87 ( ) 11 (10) 2.28 ( ) Village Konkourouna (23) 1 < (3) Kofila (6) 0.18 ( ) 15 (7) 2.71 ( ) Lena (19) 0.75 ( ) 16 (5) 1.86 ( ) NE, no estimate due to empty cells. Univariate logistic regression models. Due to missing data, not all N in categories sum up to 617. Self-reported information during previous 2 months. àobserved during swabbing. season, this carriage surge may lead to a meningitis epidemic. Thus, respiratory infection outbreaks may be a trigger for a surge in meningococcal carriage leading to an epidemic. In addition, there may be increased risk for invasive meningococcal disease during viral infection. Several agents are known to occasionally cause epidemics of respiratory infections, including mycoplasma, respiratory syncytial virus, influenza virus, adenoviruses, and others (CDC Manual 2000). Although their peak incidence in the tropical zone is reported during the wet season, some outbreaks may occur during the dry season under specific conditions. Our study does not allow any conclusion as to whether the observed effect exists specifically for one pathogen or for respiratory viruses in general. Symptoms of respiratory tract infection in our study could have been caused by nasopharyngeal NmA colonisation (Lapeyssonnie 1963). However, symptoms during the month before carriage assessment were associated with carriage, which points to a separate disease entity. We did not include a control group in a non-epidemic condition, which would be required to show that the observed association is specific for carriage of outbreak strains. However, NmY carriage in our study was not associated with respiratory tract symptoms, and the results from the 2003 carriage study in nearby Bobo-Dioulasso outside an epidemic suggest that respiratory tract infection symptoms are not associated with higher risk of meningococcal carriage in general. The association between epidemic meningococcal carriage and respiratory tract infection epidemics is not necessarily specific for NmA, given reports for serogroup B, C, and W135 meningococcal disease in the context of viral epidemics (Young et al. 1972; Cartwright et al. 1991; Huber et al. 1992; Raghunathan et al. 2006), but NmA may be most susceptible for stimuli of transmission and colonisation. While a given districts in the meningitis belt will experience hyperendemic meningitis incidence during each dry season, epidemics occur irregularly and are often limited to a few villages. Clonal waves of new meningococcal strains and low strain-specific seroprevalence have been hypothesized to increase epidemic risk (Leimkugel et al. 2007), but they fail to explain why epidemics in Africa occur in such a geographically focussed manner. Focal outbreaks of respiratory tract infections could help to explain this characteristic. ª 2008 Blackwell Publishing Ltd 1549

8 NmA NmY OR (95% CI) Global P-value OR (95% CI) Global P-value Table 4 Risk factors of serogroup A and Y meningococcal carriage during an NmA epidemic. Burkina Faso, March 2006 Age (years) ( ) ( ) ( ) ( ) Sex Female Male 2.41 ( ) Village Konkourouna Kofila 0.25 ( ) Lena 0.93 ( ) Daily exposure to cigarette smoke No Yes 2.51 ( ) 5 persons sharing the bedroom with participant No Yes 0.44 ( ) Number of persons sharing the (evening) meal with participant ( ) > ( ) Participation in meeting >10 persons during previous week No Yes 2.16 ( ) Recent sore throatà No 1 < Yes 3.41 ( ) Rhinitis No Yes 2.56 ( ) Meningitis case in compound during last month No Yes 2.53 ( ) Parsimonious multivariate models (variables P < 0.10). Variable does not remain in final model with selection P < àself-reported information during previous 2 months. Observed during swabbing. Longitudinal analyses of the 2003 data allowed quantifying the association of air humidity and carriage while taking into account other time-dependent variables and correlations induced by sampling design. It is possible that the doubling of NmNG acquisition risk with air humidity 40% compared to lower levels could be explained by some other unknown calendar-related factor, e.g., school vacation, but this factor would not explain the observed gradual increase in carriage or the association of higher air humidity with maintenance of carriage after acquisition as shown in the survival analysis. The correlation between climate and meningitis has been extensively studied, with evidence supporting a causal relation between low air humidity during the dry season and meningococcal meningitis epidemiology (Thompson et al. 2006). This may result from more frequent meningococcal transmission, as suggested by a study showing higher bacterial load in dry climates (Ghipponi et al. 1971), or more frequent invasion of bacteria that colonise pharyngeal mucosa damaged by dry climate (Greenwood 1999). In our study, higher air humidity seems to have favoured NmNG carriage, or conversely, lower air humidity reduced acquisition of 1550 ª 2008 Blackwell Publishing Ltd

9 NmNG carriage and favoured their clearance from the pharynx. One possible mechanism for this is that dryer air irritates the mucosa, leading to inflammation, better perfusion with blood and increased local presence of anti-meningococcal antibody. Unencapsulated meningococci may have lower resistance against antibody-mediated clearance from the mucosa than encapsulated ones, leading to a changed proportion of unencapsulated to encapsulated strains, even without competition between meningococcal strains. This could explain the lower NmNG carriage prevalence in dry climate, while virulent meningococci showed no variation over time. In summary, dry climate could change the risk of invasive meningococcal disease by increasing the ratio of encapsulated to unencapsulated Nm in carriage, which in turn would reduce the chance for harmless contact with the bacterium and subsequent natural immunity. While awaiting high-coverage and long-lasting immunization against all meningococcal serogroups with epidemic potential in Africa (currently serogroups A, W135, X), other interventions may exist to reduce hyperendemic meningitis during the dry season and the risk of meningococcal epidemics. These interventions may target to reduce harmful effects of dry air, such as humidification of rooms, vapour inhalation or nasal washes during the dry season. Furthermore, if influenza virus was involved in the observed respiratory tract infection outbreaks, influenza vaccine may have a role and should be evaluated in a controlled trial in the meningitis belt. In Burkina Faso, we found evidence that supports a relation between respiratory tract infections and epidemic carriage of meningococci. Our data are also consistent with a causal association between higher air humidity, carriage of non-virulent meningococci and lower meningitis incidence, although further studies are needed for confirmation. After introduction of preventive group A conjugate vaccine in the meningitis belt, non-vaccine prevention strategies may exist that could decrease the risk of meningococcal meningitis due to other serogroups. Acknowledgements We thank the participants, the study field teams, and the Meteorological Service at the Bobo-Dioulasso airport, as well as the sanitary authorities of Secteur 15 and 22, Hauts-Bassins region and Burkina Faso. Special thanks to Dr Sita Kroman who conducted the study monitoring. The studies were funded by the Institute Pasteur, Paris, and the Bill and Melinda Gates Foundation (2003), and Sanofi Pasteur (2006). JEM, RSI, BMNL and BDG work for AMP, which receives substantial financial support from Sanofi Pasteur. Other authors do not have any association that might pose a conflict of interest. References Alonso JM & Taha MK (2003) Viroses respiratoires et surinfection bactériennes invasives. Archives de Pédiatrie 10, Blakebrough IS, Greenwood BM, Whittle HC, Bradley AK & Gilles HM (1982) The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. The Journal of Infectious Diseases 146, Boisier P, Nicolas P, Djibo S, et al. (2007) Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clinical Infectious Diseases 44, Cartwright KA, Jones DM, Smith AJ, Stuart JM, Kaczmarski EB & Palmer SR (1991) Influenza A and meningococcal disease. Lancet 338, Caugant DA & Nicolas P (2007) Molecular surveillance of meningococcal meningitis in Africa. Vaccine 25(Suppl. 1), A8 A11. Control of Communicable Diseases Manual (2000) Control of Communicable Diseases Manual (ed. J Chin). American Public Health Association, Washington. Ge KY & Chang SY (2001) Definition and measurement of child malnutrition. Biomedical and Environmental Sciences 4, Ghipponi P, Darrigol J, Skalova R & Cvjetanovic B (1971) Study of bacterial air pollution in an arid region of Africa affected by cerebrospinal meningitis. Bulletin of the World Health Organization 45, Greenwood B (1999) Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, Hassan-King M, Greenwood BM & Whittle HC (1979) An epidemic of meningococcal infection at Zaria, northern Nigeria. 3. Meningococcal carriage. Transactions of the Royal Society of Tropical Medicine and Hygiene 73, Huber B, Watier L, Garnerin P & Richardson S (1992) Meningococcal disease and influenza-like syndrome: a new approach to an old question. The Journal of Infectious Diseases 166, Jacoby P, Watson K, Bowman J, et al. & on behalf of the Kalgoorlie Otitis Media Research Project Team (2007) Modelling the co-occurrence of Streptococcus pneumoniae with other bacterial and viral pathogens in the upper respiratory tract. Vaccine 25, Kremastinou J, Tzanakaki G, Pagalis A, Theodondou M, Weir DM & Blackwell CC (1999) Detection of IgG and IgM to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica. FEMS Immunology and Medical Microbiology 24, LaForce FM, Konde K, Viviani S & Préziosi MP (2007) The Meningitis Vaccine Project. Vaccine 25(Suppl. 1), A97 A100. ª 2008 Blackwell Publishing Ltd 1551

10 Lapeyssonnie L (1963) La méningite cérébro-spinale en Afrique. Bulletin of the World Health Organization 28(Suppl. 1), Leimkugel J, Hodgson A, Forgor, et al. (2007) Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight-year longitudinal study in northern Ghana. PLoS Medicine 4, e101.doi: /journal.pmed Maiden MCJ, Bygraves JA, Feil E, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proceedings of the National Academy of Sciences of the United States of America 95, Makras P, Alexiou-Daniel S, Antoniadis A & Hatzigerogiou D (2001) Outbreak of meningococcal disease after an influenza B epidemic at a Hellenic Air Force Recruit Training Center. Clinical Infectious Diseases 33, Mei Z, Grummer-Strawn LM, de Onis M & Yip R (1997) The development of a MUAC-for-height reference, including a comparison to other nutritional status screening indicators. Bulletin of the World Health Organization 75, Moore PS, Hierholzer J, DeWitt W, et al. (1990) Respiratory viruses and mycoplasma as cofactors for epidemic group A meningococcal meningitis. The Journal of the American Medical Association 264, Mueller JE, Yaro S, Traoré Y, et al. (2006) Neisseria meningitidis: carriage and immunity in Burkina Faso, The Journal of Infectious Diseases 193, Mueller JE, Sangaré L, Njanpop-Lafourcade BM, et al. (2007) Molecular characteristics and epidemiology of carried meningococci in Burkina Faso, Emerging Infectious Disease Journal 13, Nicolas P, Parzy D & Martet G (1997) Pulsed-field gel electrophoresis analysis of clonal relationships among Neisseria meningitidis A strains from different outbreaks. European Journal of Clinical Microbiology and Infectious Diseases 16, Poolman JT & Abdillahi H (1988) Outer membrane protein serosubtyping of Neisseria meningitidis. European Journal of Clinical Microbiology and Infectious Diseases 7, Rabe-Hesketh S, Skrondal A & Pickles A (2002) Reliable estimation of generalized linear mixed models using adaptive quadrature. The Stata Journal 2, Rabe-Hesketh S, Skrondal A & Pickles A (2005) Maximum likelihood estimation of limited and discrete dependent variable models with nested random effects. Journal of Econometrics 128, Raghunathan PL, Jones JD, Tiendrebéogo SR, et al. (2006) Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, The Journal of Infectious Diseases 193, Taha MK (2000) Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis. Journal of Clinical Microbiology 38, Tenover FC, Arbeit RD, Goering RV, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. Journal of Clinical Microbiology 33, Thompson MC, Molesworth AM, Djingarey MH, Yameogo KR, Belanger F & Cuevas LE (2006) Potential of environmental models to predict meningitis epidemics in Africa. Tropical Medicine and International Health 11, Traoré Y, Njanpop-Lafourcade BM, Adjogble KLS, et al. (2006) The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, Clinical Infectious Diseases 43, World Health Organization (1999) Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae: WHO Communicable Disease Surveillance and Response. (WHO CDS CSR EDC 99.7). World Health Organization, Geneva. World Health Organization (2008) Epidemic and Pandemic Alert and Response (EPR). Meningococcal disease. (cited 2008 April 4) Available from meningococcal_disease/en/index.html Yazdankhah SP & Caugant DA (2004) Neisseria meningitidis: an overview of the carriage state. Journal of Medical Microbiology 53, Young SL, LaForce FM, Head JJ, Feeley JC & Bennett JV (1972) A simultaneous outbreak of meningococcal and influenza infections. The New England Journal of Medicine 287, 5 9. Corresponding Author Dr Judith E. Mueller, Agence de Médecine Préventive, rue du Dr Roux, Paris cedex 15, France. Tel.: ; Fax: ; jmueller@aamp.org 1552 ª 2008 Blackwell Publishing Ltd

Serotyping pneumococcal meningitis cases in the African meningitis belt using multiplex. PCR on cerebrospinal fluid

Serotyping pneumococcal meningitis cases in the African meningitis belt using multiplex. PCR on cerebrospinal fluid JCM Accepts, published online ahead of print on 9 December 2009 J. Clin. Microbiol. doi:10.1128/jcm.01402-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso

Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso Emergence of Epidemic Neisseria meningitidis Serogroup X Meningitis in Togo and Burkina Faso Isabelle Delrieu 1, Seydou Yaro 2, Tsidi A. S. Tamekloé 3, Berthe-Marie Njanpop-Lafourcade 1, Haoua Tall 1,

More information

Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study

Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study RESEARCH ARTICLE Open Access Definition and characterization of localised meningitis epidemics in Burkina Faso: a longitudinal retrospective study Haoua Tall 1, Stéphane Hugonnet 2, Philippe Donnen 3,

More information

The Rise and Fall of Epidemic Neisseria meningitidis Serogroup W135 Meningitis in Burkina Faso,

The Rise and Fall of Epidemic Neisseria meningitidis Serogroup W135 Meningitis in Burkina Faso, MAJOR ARTICLE The Rise and Fall of Epidemic Neisseria meningitidis Serogroup W135 Meningitis in Burkina Faso, 2002 2005 Yves Traoré, 1 Berthe-Marie Njanpop-Lafourcade, 6 Kokou-Louis-Sewonou Adjogble, 5

More information

Predicting Meningitis Risk in Africa

Predicting Meningitis Risk in Africa International Conference on Secure and Sustainable Living: Social and Economic Benefits of Weather, Climate, and Water Services Predicting Meningitis Risk in Africa M. K. Konde, M.H. Djingarey, Thomson

More information

ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study

ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina Faso: a prospective study Tropical Medicine and International Health doi:10.1111/j.1365-3156.2008.02056.x volume 13 no 6 pp 861 868 june 2008 ST2859 serogroup A meningococcal meningitis outbreak in Nouna Health District, Burkina

More information

in the meningitis belt

in the meningitis belt Biological aspects of meningitis epidemics in the meningitis belt Dr Pierre NICOLAS Meningococcus Unit, WHO collaborating centre IMTSSA, Allée du médecin colonel Jamot Parc du Pharo BP 60109 13262 Marseille

More information

MENINGITIS EPIDEMIC TRENDS in AFRICA. Mamoudou H. DJINGAREY, MD/MPH WHO-IST/WEST AFRICA OUAGADOUGOU

MENINGITIS EPIDEMIC TRENDS in AFRICA. Mamoudou H. DJINGAREY, MD/MPH WHO-IST/WEST AFRICA OUAGADOUGOU MENINGITIS EPIDEMIC TRENDS in AFRICA Mamoudou H. DJINGAREY, MD/MPH WHO-IST/WEST AFRICA OUAGADOUGOU Background Epidemic Meningococcal meningitis = a challenging public health threat in Africa. 1996: Devastating

More information

Stockpile needs for epidemic meningitis response Dr Caroline Trotter

Stockpile needs for epidemic meningitis response Dr Caroline Trotter Stockpile needs for epidemic meningitis response 2018-2022 Dr Caroline Trotter clt56@cam.ac.uk Report prepared by: Dr Caroline Trotter, University of Cambridge, UK clt56@cam.ac.uk Date: 8 th December 2017

More information

PREVENTION OF MENINGOCOCCAL MENINGITIS BY VACCINATION IN THE AFRICAN MENINGITIS BELT

PREVENTION OF MENINGOCOCCAL MENINGITIS BY VACCINATION IN THE AFRICAN MENINGITIS BELT PREVENTION OF MENINGOCOCCAL MENINGITIS BY VACCINATION IN THE AFRICAN MENINGITIS BELT Brian Greenwood London School of Hygiene & Tropical Medicine ADVAC, Annecy May 19 th 2014 Cytoplasmic proteins bacterium

More information

Impact of MenAfriVac in nine countries of the African meningitis belt, : an analysis of surveillance data

Impact of MenAfriVac in nine countries of the African meningitis belt, : an analysis of surveillance data Impact of MenAfriVac in nine countries of the African meningitis belt, 2010 15: an analysis of surveillance data Caroline L Trotter, Clément Lingani, Katya Fernandez, Laura V Cooper, André Bita, Carol

More information

Rôle et activités d un Centre Collaborateur de l OMS : le CC- OMS sur les méningites

Rôle et activités d un Centre Collaborateur de l OMS : le CC- OMS sur les méningites Rôle et activités d un Centre Collaborateur de l OMS : le CC- OMS sur les méningites Muhamed-Kheir Taha MD, PhD Invasive Bacterial Infections CNR des Méningocoques et Haemophilus influenzae WHOcc for meningitis

More information

Serogroup W in Africa & travellers

Serogroup W in Africa & travellers Serogroup W in Africa & travellers Muhamed-Kheir TAHA Institut Pasteur 01/11/2016 2 childhood meningococcal meningitis caused by this serogroup. Three infants, two with bacteremia and one with septic arthritis

More information

Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt. January 2017

Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt. January 2017 January 2017 Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt Introduction Since the progressive introduction of meningococcal serogroup A conjugate vaccine (MACV) in the

More information

Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso

Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso SUPPLEMENT ARTICLE Meningococcal Seroepidemiology 1 Year After the PsA-TT Mass Immunization Campaign in Burkina Faso Haoua Tall, 1 Seydou Yaro, 2 Hervé B. N. Kpoda, 2 Soumeya Ouangraoua, 2 Caroline L.

More information

Kristiansen et al. BMC Infectious Diseases 2013, 13:363

Kristiansen et al. BMC Infectious Diseases 2013, 13:363 Kristiansen et al. BMC Infectious Diseases 2013, 13:363 RESEARCH ARTICLE Open Access Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass

More information

Epidemiological patterns of bacterial meningitis in Niger from 2002 to 2010

Epidemiological patterns of bacterial meningitis in Niger from 2002 to 2010 Science Journal of Public Health 4; (): 8-63 Published online February, 4 (http://www.sciencepublishinggroup.com/j/sjph) doi:.648/j.sjph.4.3 Epidemiological patterns of bacterial meningitis in Niger from

More information

Meningitis Outbreak Response intervention thresholds in sub-saharan Africa

Meningitis Outbreak Response intervention thresholds in sub-saharan Africa Meningitis Outbreak Response intervention thresholds in sub-saharan Africa Report for the WHO Meningitis Guideline Revision May 2014 Prepared by Dr Caroline Trotter (clt56@cam.ac.uk) Recommendation question:

More information

Report for the WHO Meningitis Guideline Revision (May 2014)

Report for the WHO Meningitis Guideline Revision (May 2014) Antibiotic Regimens in meningitis epidemics in sub-saharan Africa: Report for the WHO Meningitis Guideline Revision (May 2014) Prepared by Laurence Cibrelus Recommendation question: Should single dose

More information

Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135

Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135 Transactions of the Royal Society of Tropical Medicine and Hygiene (2006) 100, 573 578 available at www.sciencedirect.com journal homepage: www.elsevierhealth.com/journals/trst Evaluation of the Pastorex

More information

J. M. COLLARD 1 *, Z. MAMAN 2,A.ABANI 2,H.B.MAINASARA 1,S.DJIBO 1, H. YACOUBA 2,R.MAITOURNAM 2, F. SIDIKOU 1, P. NICOLAS 3, J.

J. M. COLLARD 1 *, Z. MAMAN 2,A.ABANI 2,H.B.MAINASARA 1,S.DJIBO 1, H. YACOUBA 2,R.MAITOURNAM 2, F. SIDIKOU 1, P. NICOLAS 3, J. Epidemiol. Infect. (2011), 139, 1656 1660. f Cambridge University Press 2011 doi:10.1017/s0950268810003092 SHORT REPORT Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup

More information

Published by Centers for Disease Control (CDC) Archived on this site by permission of CDC, [url]http://www.cdc.gov/ncidod/eid[/url]

Published by Centers for Disease Control (CDC) Archived on this site by permission of CDC, [url]http://www.cdc.gov/ncidod/eid[/url] MSF Field Research Continuing effectiveness of serogroup a meningococcal conjugate vaccine, Chad, 2013 Authors Gamougam, K; Daugla, D M; Toralta, J; Ngadoua, C; Fermon, F; Page, A-L; Djingarey, M H; Caugant,

More information

Meningitis January Dr Andrew Lee Consultant in Communicable Disease Control, PHE Information in this slide set was correct as of 21.1.

Meningitis January Dr Andrew Lee Consultant in Communicable Disease Control, PHE Information in this slide set was correct as of 21.1. Meningitis January 2016 Dr Andrew Lee Consultant in Communicable Disease Control, PHE Information in this slide set was correct as of 21.1.16 Outline What is meningitis What causes it What are the signs

More information

Background: Meningococcal Disease on Campus

Background: Meningococcal Disease on Campus Health Services 229.931.2235 OFFICE 229.931.2666 FAX health@canes.gsw.edu Overview of Meningococcal Disease 800 Georgia Southwestern State University Drive Americus, Georgia 31709-4379 Background: Meningococcal

More information

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a Meningococcal Serogroup A Conjugate Vaccine CLINICAL AND VACCINE IMMUNOLOGY, Mar. 2011, p. 435 443 Vol. 18, No. 3 1556-6811/11/$12.00 doi:10.1128/cvi.00479-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Baseline Meningococcal

More information

Incidence, Seasonality, Age Distribution, and Mortality of Pneumococcal Meningitis in Burkina Faso and Togo

Incidence, Seasonality, Age Distribution, and Mortality of Pneumococcal Meningitis in Burkina Faso and Togo SUPPLEMENT ARTICLE Incidence, Seasonality, Age Distribution, and Mortality of Pneumococcal Meningitis in Burkina Faso and Togo Yves Traore, 1 Tsidi Agbeko Tameklo, 4 Berthe-Marie Njanpop-Lafourcade, 5

More information

Can infant vaccination prevent pneumococcal meningitis outbreaks in sub-saharan Africa?

Can infant vaccination prevent pneumococcal meningitis outbreaks in sub-saharan Africa? Editorial Can infant vaccination prevent pneumococcal meningitis outbreaks in sub-saharan Africa? Author: James M Stuart, FFPH London School of Hygiene and Tropical Medicine, Keppel St, London WC1E 7HT,

More information

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 3, April 30, 2012 Vol. 2 Issue 3, April 30, 2012 Content Introduction Overview of reported outbreaks in the WHO African Region Cholera Meningitis Ongoing outbreaks Lassa Fever in Nigeria Typhoid in Zimbabwe Meningitis in

More information

Carriage and transmission of Neisseria meningitidis

Carriage and transmission of Neisseria meningitidis Chapter 2 Carriage and transmission of Neisseria meningitidis Caroline L Trotter, Martin CJ Maiden Introduction Despite the fact that the meningococcus is a pathogen of global significance, causing the

More information

Epidemic meningitis: Surveillance and response activities during the season in the countries of the African meningitis belt

Epidemic meningitis: Surveillance and response activities during the season in the countries of the African meningitis belt Epidemic meningitis: Surveillance and response activities during the 2002 2003 season in the countries of the African meningitis belt Report on an informal WHO consultation Geneva, 24 25 July 2003 Department

More information

History, implementation and impact of MenA conjugate on disease burden in Africa

History, implementation and impact of MenA conjugate on disease burden in Africa History, implementation and impact of MenA conjugate on disease burden in Africa First Regional Meningococcal Symposium, 19-20 March 2012 Buenos Aires, Argentina Co-hosted by the Sabin Vaccine Institute

More information

Global Burden of Meningococcal Disease. Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci. Centre for Global Health Security, Chatham House, London.

Global Burden of Meningococcal Disease. Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci. Centre for Global Health Security, Chatham House, London. Global Burden of Meningococcal Disease Prof. David Salisbury CB FRCP FRCPCH FFPH FMedSci. Centre for Global Health Security, Chatham House, London. Neisseria meningitidis Gram negative diplococci. Ten

More information

National Institute for Communicable Diseases -- Weekly Surveillance Report --

National Institute for Communicable Diseases -- Weekly Surveillance Report -- Weekly Surveillance Report Week 43, 216 National Institute for Communicable Diseases -- Weekly Surveillance Report -- Page 2 Laboratory-Based Respiratory & Meningeal Disease Surveillance 3 Neisseria meningitidis

More information

Sporadic Cases of Meningococcal Meningitis Serogroup W-135 Ethiopia, 2013

Sporadic Cases of Meningococcal Meningitis Serogroup W-135 Ethiopia, 2013 Clinical Neurology and Neuroscience 2017; 1(3): 70-75 http://www.sciencepublishinggroup.com/j/cnn doi: 10.11648/j.cnn.20170103.15 Sporadic Cases of Meningococcal Meningitis Serogroup W-135 Ethiopia, 2013

More information

Örebro University Hospital

Örebro University Hospital Örebro University Hospital Department of Laboratory Medicine Susanne Jacobsson Date: 2015-02-18 Page 1 (8) Neisseria meningitidis 2014 Annual report concerning serogroup, genosubtype and antibiotic susceptibility

More information

Surveillance Feedback Bulletin

Surveillance Feedback Bulletin Surveillance Feedback Bulletin 2017 Combined Quarter 3 & 4 Quarterly feedback bulletin on bacterial meningitis Table 1. Epidemiological situation, week 27-52 99% of suspect cases reported in the MenAfriNet

More information

Meningococcal meningitis

Meningococcal meningitis Etiological Agent: Neisseria meningitis (1) Meningococcal meningitis By Tho Dao Transmission The transmission of Neisseria meningitis is through direct contact from person to person via droplets or throat

More information

Appendix A: Disease-Specific Chapters

Appendix A: Disease-Specific Chapters Ministry of Health and Long-Term Care Infectious Diseases Protocol Appendix A: Disease-Specific Chapters Chapter: Haemophilus influenzae disease, all types, invasive Effective: May 2018 Haemophilus influenzae,

More information

Public health impact of MenAfriVac: the first four years

Public health impact of MenAfriVac: the first four years 1 Public health impact of MenAfriVac: the first four years Mamoudou Djingarey, WHO Ryan Novak, CDC James Stuart, LSHTM MVP Closure Conference, Addis Ababa, Ethiopia 23 February 2016 MACV Implementa;on

More information

Malik Sallam. Ola AL-juneidi. Ammar Ramadan. 0 P a g e

Malik Sallam. Ola AL-juneidi. Ammar Ramadan. 0 P a g e 1 Malik Sallam Ola AL-juneidi Ammar Ramadan 0 P a g e Today's lecture will be about viral upper respiratory tract infections. Those include: common cold, sinusitis, otitis, etc. Infections in the upper

More information

DUST AND MENINGITIS IN SUB-SAHARAN AFRICA

DUST AND MENINGITIS IN SUB-SAHARAN AFRICA DUST AND MENINGITIS IN SUB-SAHARAN AFRICA Carlos Pérez García-Pando NASA Goddard Institute for Space Studies Dept of Applied Physics and Applied Math, Columbia University 1st AFRICA/MIDDLE-EAST EXPERT

More information

Outcome of Epidemiological Surveillance of Bacterial Meningitis in Mali from 1996 to 2016: What Lesson to Learn?

Outcome of Epidemiological Surveillance of Bacterial Meningitis in Mali from 1996 to 2016: What Lesson to Learn? Research Article imedpub Journals http://www.imedpub.com/ Journal of MPE Molecular Pathological Epidemiology Outcome of Epidemiological Surveillance of Bacterial Meningitis in Mali from 1996 to 2016: What

More information

Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso

Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso Ba et al. BMC Infectious Diseases 2014, 14:546 RESEARCH ARTICLE Open Access Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina

More information

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 4, 26 May 2012

Content. Introduction. Overview of reported outbreaks in WHO African Region. Disease Surveillance and Response. Vol. 2 Issue 4, 26 May 2012 Vol. 2 Issue 4, 26 May 2012 Content Introduction Overview of reported outbreaks in the WHO African Region Cholera Meningitis Ongoing outbreaks Cholera in Ghana Cholera in Mozambique Cholera in Uganda Cholera

More information

Biology of Neisseria meningitidis: implications for vaccine development Richard Moxon: University of Oxford

Biology of Neisseria meningitidis: implications for vaccine development Richard Moxon: University of Oxford Biology of Neisseria meningitidis: implications for vaccine development Richard Moxon: University of Oxford Biology of N.meningitidis infection Within hours, the disease may progress to shock with multi-organ

More information

Downloaded from:

Downloaded from: Granerod, J; Davison, KL; Ramsay, ME; Crowcroft, NS (26) Investigating the aetiology of and evaluating the impact of the Men C vaccination programme on probable meningococcal disease in England and Wales.

More information

in control group 7, , , ,

in control group 7, , , , Q1 Rotavirus is a major cause of severe gastroenteritis among young children. Each year, rotavirus causes >500,000 deaths worldwide among infants and very young children, with 90% of these deaths occurring

More information

Dust and meningitis. A multidisciplinary work Preliminary results

Dust and meningitis. A multidisciplinary work Preliminary results Dust and meningitis A multidisciplinary work Preliminary results I. JEANNE 1, A. DEFOSSEZ 2, JL RAJOT 3, K.KIARI 4, M. KALACHE 1, P. BOISIER 1 CERMES, ENSG, IRD-Niamey, SNIS ESA - AMMA-Eu - Institut Pasteur

More information

Epidemiology of hepatitis E infection in Hong Kong

Epidemiology of hepatitis E infection in Hong Kong RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Epidemiology of hepatitis E infection in Hong Kong DPC Chan *, KCK Lee, SS Lee K e y M e s s a g e s 1. The overall anti hepatitis E virus (HEV) seropositivity

More information

Bacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B.

Bacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B. UvA-DARE (Digital Academic Repository) Bacterial meningitis in adults: Host and pathogen factors, treatment and outcome Heckenberg, S.G.B. Link to publication Citation for published version (APA): Heckenberg,

More information

INFLUENZA Surveillance Report Influenza Season

INFLUENZA Surveillance Report Influenza Season Health and Wellness INFLUENZA Surveillance Report 2011 2012 Influenza Season Population Health Assessment and Surveillance Table of Contents Introduction... 3 Methods... 3 Influenza Cases and Outbreaks...

More information

TRANSPARENCY COMMITTEE OPINION. 4 March 2009

TRANSPARENCY COMMITTEE OPINION. 4 March 2009 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 4 March 2009 MENCEVAX powder and solvent for solution for injection Meningococcal polysaccharide vaccine for serogroups

More information

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a. Meningococcal Serogroup A Conjugate Vaccine.

Baseline Meningococcal Carriage in Burkina Faso before the Introduction of a. Meningococcal Serogroup A Conjugate Vaccine. CVI Accepts, published online ahead of print on 12 January 2011 Clin. Vaccine Immunol. doi:10.1128/cvi.00479-10 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.

More information

Vaccines. Robert Read University of Southampton University Hospital Southampton

Vaccines. Robert Read University of Southampton University Hospital Southampton Vaccines Robert Read University of Southampton University Hospital Southampton Disclosures Non personal, non specific; Novartis-GSK Member, JCVI Editor in Chief, Journal of Infection, and Current Opinion

More information

MSF Field Research. Biological diagnosis of meningococcal meningitis in the. meningitis belt: current epidemic strategy and new perspectives.

MSF Field Research. Biological diagnosis of meningococcal meningitis in the. meningitis belt: current epidemic strategy and new perspectives. MSF Field Research Biological diagnosis of meningococcal meningitis in the African meningitis belt: current epidemic strategy and new perspectives. Item type Authors Citation DOI Publisher Journal Rights

More information

THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE

THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE THIS ACTIVITY HAS EXPIRED. CME CREDIT IS NO LONGER AVAILABLE The following content is provided for informational purposes only. PREVENTION AND CONTROL OF INFLUENZA Lisa McHugh, MPH Influenza can be a serious

More information

1.3 Meningococcal Disease (Neisseria meningitidis) (invasive)

1.3 Meningococcal Disease (Neisseria meningitidis) (invasive) 1.3 Meningococcal Disease (Neisseria meningitidis) (invasive) Summary Number of cases, 214: 82 Number of cases, 213: 81 Number of cases, 212: 66 Crude incidence rate, 214:1.8/1, Between and 212, a marked

More information

Community outbreak of group B meningococcal disease in southwest France December 2008 to September 2009

Community outbreak of group B meningococcal disease in southwest France December 2008 to September 2009 Surveillance and outbreak reports Community outbreak of group B meningococcal disease in southwest France December 2008 to September 2009 E Delisle (elsa.delisle@ars.sante.fr) 1,2, S Larrieu 1, J Simões

More information

Health care workers and infectious diseases

Health care workers and infectious diseases Introduction Health care workers and infectious diseases Objectives 1. What is an infectious disease?? 2. What is an infection and disease?? 3. Causes of re-emerging of the problem of the infectious diseases

More information

2017/18 Influenza Season Summary

2017/18 Influenza Season Summary 2017/18 Influenza Season Summary April 2019 Author Dinna Lozano, Epidemiologist Planning and Evaluation Services Email: research@healthunit.ca Contents Key Findings... 2 Influenza Rates over Time... 2

More information

Medical Innovation changing business model. Marie-Paule Kieny, WHO-WIPO-WTO, 5 July 2013

Medical Innovation changing business model. Marie-Paule Kieny, WHO-WIPO-WTO, 5 July 2013 Medical Innovation changing business model Marie-Paule Kieny, WHO-WIPO-WTO, 5 July 2013 The Meningitis Vaccine Project (MVP) A successful vaccine development for Africa, partnering with a DCVM An exemplary

More information

EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002

EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002 EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002 Robyn Gilmour Communicable Diseases Branch NSW Department of Health BACKGROUND Infection with the bacterium Streptococcus pneumoniae is a major cause

More information

Influenza Weekly Surveillance Bulletin

Influenza Weekly Surveillance Bulletin Influenza Weekly Surveillance Bulletin Northern Ireland, Week 1 (2 January 217 8 January 217) Summary At this point in the 216/17 influenza season, activity has increased in week 1 (week commencing 9 th

More information

Situation update pandemic (H1N1) 2009

Situation update pandemic (H1N1) 2009 Situation update pandemic (H1N1) 2009 February 2010 USPACOM/COE Pandemic Influenza Workshop Overview Overview of Events Pandemic (H1N1) 2009 Issues/Concerns 2 Overview of events April 12: an outbreak of

More information

Multicomponent MenB Vaccine (4CMenB): An Innovative Step In the Global Fight Against Serogroup B Meningococcal Disease

Multicomponent MenB Vaccine (4CMenB): An Innovative Step In the Global Fight Against Serogroup B Meningococcal Disease Multicomponent MenB Vaccine (4CMenB): An Innovative Step In the Global Fight Against Serogroup B Meningococcal Disease Jeffrey J. Stoddard, MD, FAAP Head, Global Medical Affairs Novartis Vaccines and Diagnostics

More information

HAEMOPHILUS INFLUENZAE INVASIVE DISEASE

HAEMOPHILUS INFLUENZAE INVASIVE DISEASE 23 Annual Morbidity Report HAEMOPHILUS INFLUENZAE INVASIVE DISEASE CRUDE DATA 35 Annual Incidence a LA County.37 California b. United States c.2 Age at Diagnosis Mean 4. years Median 36. years Range Birth

More information

Meningococcal Disease a resurgence of an old foe?

Meningococcal Disease a resurgence of an old foe? Meningococcal Disease a resurgence of an old foe? To talk about NZ rates of meningococcal disease Changing serotypes Clinical presentations Meningococcal vaccines What is meningococcal disease? Important

More information

Bacterial diseases caused by Streptoccus pneumoniae in children

Bacterial diseases caused by Streptoccus pneumoniae in children Bacterial diseases caused by Streptoccus pneumoniae in children Bactermia 85% Bacterial pneumonia 66% Bacterial meningitis 50% Otitis media 40% Paranasal sinusitis 40% 0% 10% 20% 30% 40% 50% 60% 70% 80%

More information

MENINGOCOCCAL MENINGITIS 101. An Overview for Parents, Teachers, Students and Communities

MENINGOCOCCAL MENINGITIS 101. An Overview for Parents, Teachers, Students and Communities MENINGOCOCCAL MENINGITIS 101 An Overview for Parents, Teachers, Students and Communities 2013 Meningococcal Disease Fast Facts Meningococcal disease is the result of a rare, but serious bacterial infection

More information

Surveillance of influenza in Northern Ireland

Surveillance of influenza in Northern Ireland Surveillance of influenza in Northern Ireland 2011-2012 Summary: The influenza season started later than normal, clinical indices began to increase marginally in mid-february, much later than previous

More information

Influenza Weekly Surveillance Bulletin

Influenza Weekly Surveillance Bulletin Influenza Weekly Surveillance Bulletin Northern Ireland, Weeks 50-51 (11 th December 24 th December 2017) Summary Influenza activity across Northern Ireland increased in weeks 50 and 51 (weeks commencing

More information

بسم هللا الرحمن الرحيم

بسم هللا الرحمن الرحيم - 1 - - - 1 P a g e بسم هللا الرحمن الرحيم This sheet was made from record section 1 all information are included - Introduction Our respiratory tract is divided anatomically to upper (URT),middle and

More information

A Summary of the UCAR Google.o Weather and Meningitis Project

A Summary of the UCAR Google.o Weather and Meningitis Project A Summary of the UCAR Google.o Weather and Meningitis Project Project Personnel: Abudulai Adams-Forgor 1, Mary Hayden 2, Abraham Hodgson 1, Thomas Hopson 2, Benjamin Lamptey 3, Jeff Lazo 2, Raj Pandya

More information

Streptococcus Pneumoniae

Streptococcus Pneumoniae Streptococcus Pneumoniae (Invasive Pneumococcal Disease) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report by mail or by electronic

More information

Seasonality of influenza activity in Hong Kong and its association with meteorological variations

Seasonality of influenza activity in Hong Kong and its association with meteorological variations Seasonality of influenza activity in Hong Kong and its association with meteorological variations Prof. Paul Chan Department of Microbiology The Chinese University of Hong Kong Mr. HY Mok Senior Scientific

More information

Downloaded from:

Downloaded from: Diomand, FV; Djingarey, MH; Daugla, DM; Novak, RT; Kristiansen, PA; Collard, JM; Gamougam, K; Kandolo, D; Mbakuliyemo, N; Mayer, L; Stuart, J; Clark, T; Tevi-Benissan, C; Perea, WA; Preziosi, MP; Marc

More information

Influenza Activity in Indiana

Influenza Activity in Indiana Objectives of Influenza Surveillance Influenza Activity in Indiana 2014-2015 Reema Patel, MPH Respiratory Epidemiologist Epidemiology Resource Center Indiana State Department of Health Monitor influenza-like

More information

Epidemiological Dynamics of a Bacterial Meningitis Outbreak in Two Districts in Northern Ghana

Epidemiological Dynamics of a Bacterial Meningitis Outbreak in Two Districts in Northern Ghana Open Access Library Journal 2016, Volume 3, e2993 ISSN Online: 2333-9721 ISSN Print: 2333-9705 Epidemiological Dynamics of a Bacterial Meningitis Outbreak in Two Districts in Northern Ghana Franklin Asiedu-Bekoe

More information

Influenza : What is going on? How can Community Health Centers help their patients?

Influenza : What is going on? How can Community Health Centers help their patients? Influenza 2008-2009: What is going on? How can Community Health Centers help their patients? Beth Nivin Bureau of Communicable Diseases New York City Dept. of Health and Mental Hygiene By the end of this

More information

Environmental survival of Neisseria meningitidis

Environmental survival of Neisseria meningitidis Environmental survival of Neisseria meningitidis Yih-Ling Tzeng, Emory University L.E. Martin, Emory University David Stephens, Emory University Journal Title: Epidemiology and Infection Volume: Volume

More information

Below you will find information about diseases, the risk of contagion, and preventive vaccinations.

Below you will find information about diseases, the risk of contagion, and preventive vaccinations. Vaccinations Below you will find information about diseases, the risk of contagion, and preventive vaccinations. DTP - Diphtheria Tetanus Polio Yellow fever Hepatitis A Typhoid fever Cerebrospinal meningitis

More information

Seasonal Influenza in Alberta 2010/2011 Summary Report

Seasonal Influenza in Alberta 2010/2011 Summary Report Seasonal Influenza in Alberta 21/211 Summary Report Government of Alberta October 211 ISSN 1927-4114, Surveillance and Assessment Branch Send inquiries to: Health.Surveillance@gov.ab.ca Executive Summary

More information

INSTITUTE OF PHYSICS

INSTITUTE OF PHYSICS FEDERAL UNIVERSITY OF SOUTH MATO GROSSO INSTITUTE OF PHYSICS IMPACTS OF CLIMATE VARIABILITY ON RESPIRATORY MORBIDITY. AUTOR: AMAURY DE SOUZA, FLAVIO ARISTONE, ANA PAULA BERTOSSI OHIO 2014 PROBLEM SITUATION

More information

Respiratory System Virology

Respiratory System Virology Respiratory System Virology Common Cold: Rhinitis. A benign self limited syndrome caused by several families of viruses. The most frequent acute illness in industrialized world. Mild URT illness involving:

More information

Influenza Weekly Surveillance Bulletin

Influenza Weekly Surveillance Bulletin Influenza Weekly Surveillance Bulletin Northern Ireland, Week 1 (1 st January 7 th January 2018) Summary GP consultation rates increased while OOH consultation rates decreased in week 1, (week commencing

More information

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES

A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES A UNIQUE NETWORK OF EXPERTISE DEDICATED TO THE FIGHT AGAINST INFECTIOUS DISEASES Since 1888, date of its creation, has been committed to contain infectious diseases by working directly in regions where

More information

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 1. Does my country need JE vaccine?

Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 1. Does my country need JE vaccine? Navigating vaccine introduction: a guide for decision-makers JAPANESE ENCEPHALITIS (JE) Module 1 Does my country need JE vaccine? 1 about this guide Japanese encephalitis (JE), a viral infection of the

More information

MODELLING INFECTIOUS DISEASES. Lorenzo Argante GSK Vaccines, Siena

MODELLING INFECTIOUS DISEASES. Lorenzo Argante GSK Vaccines, Siena MODELLING INFECTIOUS DISEASES Lorenzo Argante GSK Vaccines, Siena lorenzo.x.argante@gmail.com GSK IN A NUTSHELL GSK VACCINES - GLOBAL PRESENCE SIENA RESEARCH AND DEVELOPMENT (R&D) SITE EXPLORATORY DATA

More information

Predicting meningococcal meningitis outbreaks in Niger: current progress

Predicting meningococcal meningitis outbreaks in Niger: current progress Predicting meningococcal meningitis outbreaks in Niger: current progress Laurence Cibrelus, for the study group 2 nd MERIT Meeting, Ethiopia, December 2008 Study group: Jean-François Jusot, Hugo Oliveros,

More information

Local Public Health Department. Communicable diseases Environmental health Chronic diseases Emergency preparedness Special programs

Local Public Health Department. Communicable diseases Environmental health Chronic diseases Emergency preparedness Special programs Susan I. Gerber, MD Local Public Health Department Communicable diseases Environmental health Chronic diseases Emergency preparedness Special programs Public Health Reporting Ground Zero Local government

More information

Downloaded from:

Downloaded from: Greenwood, B (2013) Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt. Vaccine. ISSN 0264-410X DOI: https://doi.org/10.1016/j.vaccine.2012.12.035

More information

PUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA

PUBLIC HEALTH SIGNIFICANCE SEASONAL INFLUENZA AVIAN INFLUENZA SWINE INFLUENZA INFLUENZA DEFINITION Influenza is an acute highly infectious viral disease characterized by fever, general and respiratory tract catarrhal manifestations. Influenza has 3 Types Seasonal Influenza Avian

More information

Neisseria meningitidis; clones, carriage, and disease

Neisseria meningitidis; clones, carriage, and disease REVIEW 10.1111/1469-0691.12647 Neisseria meningitidis; clones, carriage, and disease R. C. Read Clinical and Experimental Sciences and NIHR Respiratory Biomedical Research Unit, Faculty of Medicine, University

More information

Analysis of phenotypic variants of the serogroup C ET-15 clone of Neisseria meningitidis by pulsed-field gel electrophoresis.

Analysis of phenotypic variants of the serogroup C ET-15 clone of Neisseria meningitidis by pulsed-field gel electrophoresis. JCM Accepts, published online ahead of print on 9 May 2007 J. Clin. Microbiol. doi:10.1128/jcm.00908-07 Copyright 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

PROCEDURE FOR DEALING WITH MENINGITIS AND MENINGOCOCCAL DISEASE

PROCEDURE FOR DEALING WITH MENINGITIS AND MENINGOCOCCAL DISEASE PROCEDURE FOR DEALING WITH MENINGITIS AND MENINGOCOCCAL DISEASE 1 INTRODUCTION 1.1 Purpose of Procedure To ensure that the University has clear guidelines on preventing or managing cases of meningitis

More information

INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES

INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES Upper Respiratory Tract Infections Return to Syllabus INTRODUCTION TO UPPER RESPIRATORY TRACT DISEASES General Goal: To know the major mechanisms of defense in the URT, the major mechanisms invaders use

More information

Preventive immunisation could reduce the risk of meningococcal epidemics in the African meningitis belt

Preventive immunisation could reduce the risk of meningococcal epidemics in the African meningitis belt Annals of Tropical Medicine & Parasitology, Vol. 93, No. 5, 505-510 (1999) Preventive immunisation could reduce the risk of meningococcal epidemics in the African meningitis belt BY ;$P&PAUx* Centre de

More information

Annual Report of the National Center for Meningococci 2005

Annual Report of the National Center for Meningococci 2005 Annual Report of the National Center for Meningococci 2005 Béatrice Ninet, Peter Rohner, Jacques Schrenzel Hôpitaux Universitaires de Genève Laboratoire Central de Bactériologie 24 rue Micheli-du-Crest

More information

8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 2013 (covering week )

8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 2013 (covering week ) 8 Public Health Wales CDSC Weekly Influenza Surveillance Report Wednesday 21 August 213 (covering week 33 213) Current level of activity: Low Trend: Stable compared to last week News: Update Middle East

More information

TRENDS IN PNEUMONIA AND INFLUENZA MORBIDITY AND MORTALITY

TRENDS IN PNEUMONIA AND INFLUENZA MORBIDITY AND MORTALITY TRENDS IN PNEUMONIA AND INFLUENZA MORBIDITY AND MORTALITY AMERICAN LUNG ASSOCIATION RESEARCH AND PROGRAM SERVICES EPIDEMIOLOGY AND STATISTICS UNIT February 2006 TABLE OF CONTENTS Trends in Pneumonia and

More information